Associate Professor Juanita L. Breen has an extensive background in community pharmacy, especially in aged care. During her Ph.D. at the University of Tasmania she developed the RedUSe (Reducing Use of Sedatives) program, the first national intervention aimed at reducing antipsychotic and benzodiazepine use in residential aged care homes. To date, the program has been run in 300 homes and was recognized with a mental-health award for education, training, and professional development and her paper was awarded the Stawell award for the most impactful paper published in the Medical Journal of Australia in 2019. Dr Breen presented her work at the Australian Royal Commission into Aged Care and now consults for the Aged Care Quality and Safety Commission, completes medication reviews, provides staff education, and continues to research and improve medication use in aged care.
Associate Professor Juanita L. Breen has an extensive background in community pharmacy, especially in aged care. During her Ph.D. at the University of Tasmania she developed the RedUSe (Reducing Use of Sedatives) program, the first national intervention aimed at reducing antipsychotic and benzodiazepine use in residential aged care homes. To date, the program has been run in 300 homes and was recognized with a mental-health award for education, training, and professional development and her paper was awarded the Stawell award for the most impactful paper published in the Medical Journal of Australia in 2019. Dr Breen presented her work at the Australian Royal Commission into Aged Care and now consults for the Aged Care Quality and Safety Commission, completes medication reviews, provides staff education, and continues to research and improve medication use in aged care.